QScreen AI Inc. PMEDF

Company Overview

QScreen AI Inc. (OTCQB: PMEDF) is a technology company focused on artificial intelligence–enabled health and safety screening solutions. Public disclosures and market filings indicate the company has historically operated under the name Predictmedix AI Inc. and has developed systems intended for rapid, contactless health risk assessment in workplace, industrial, and public-access environments. Its offerings have been associated with AI-driven screening applications that analyze physiological and behavioral indicators through camera-based systems and software analytics.

The company’s reported business focus has centered on workplace safety, health monitoring, and security-related screening technologies for enterprise and institutional customers. Publicly available information indicates activity in sectors including occupational health, industrial safety, transportation, education, and public venue monitoring. Available disclosures suggest the company’s strategic positioning has emphasized non-invasive screening tools powered by machine learning and computer vision technologies. Data regarding the company’s current scale, customer concentration, and revenue mix remains limited in publicly accessible filings and market coverage. Some operational details are inconclusive based on available public sources.

Business Operations

QScreen AI’s operations have historically been centered around AI-based screening and monitoring platforms designed to detect indicators associated with impairment, fatigue, illness risk, or behavioral anomalies. Public company materials and securities disclosures indicate that the company has promoted software-driven screening systems combining thermal imaging, computer vision, and predictive analytics. Revenue generation has reportedly been tied to software licensing, technology deployments, pilot programs, and commercial agreements related to workplace and institutional screening solutions.

The company has referenced operations and commercial activity in both North America and international markets, though detailed segment-level financial disclosures appear limited. Public materials have also referenced collaborations with technology integrators, channel partners, and institutional customers. Information regarding material subsidiaries, large-scale joint ventures, or significant recurring revenue contracts is not comprehensively disclosed in widely available filings. Data inconclusive based on available public sources.

Strategic Position & Investments

Public statements and investor-facing materials indicate that QScreen AI has pursued growth through expansion of AI-enabled workplace safety and health screening applications. The company has historically emphasized the development of scalable screening systems capable of deployment in industrial facilities, transportation hubs, healthcare settings, and public infrastructure environments. Its strategy appears to focus on combining automation, predictive analytics, and remote monitoring capabilities to address occupational safety and compliance requirements.

The company has also highlighted involvement in emerging AI and computer vision technologies related to health analytics and behavioral assessment. Available disclosures suggest continued investment in software development, machine learning models, and commercialization partnerships. Publicly accessible information does not clearly confirm major acquisitions or a broad portfolio of controlled subsidiaries. While earlier corporate materials referenced technology partnerships and pilot deployments, the long-term commercial impact of those initiatives cannot be independently verified from currently available public information.

Geographic Footprint

QScreen AI has historically maintained a corporate presence in Canada, with public market activity tied to both Canadian and U.S. over-the-counter trading venues. Public disclosures indicate commercial outreach and pilot initiatives across North America, with references to additional activity in international jurisdictions including parts of Asia and other overseas markets. The company’s technology positioning has been oriented toward customers seeking workplace screening and safety monitoring solutions across industrial and institutional environments.

The extent of the company’s active operational footprint, installed customer base, and international revenue contribution is not comprehensively detailed in publicly available reporting. While company materials have referenced cross-border commercial engagements and international deployment opportunities, independently verified operational scale outside Canada remains limited based on available public filings and financial disclosures.

Leadership & Governance

QScreen AI’s leadership has historically included executives associated with the company’s AI commercialization, health technology development, and public market strategy. Public records and company disclosures indicate continuity from the earlier Predictmedix AI Inc. corporate structure into the current branding framework. Leadership communications have generally emphasized AI-driven workplace safety, scalable screening technologies, and enterprise adoption of automated health-monitoring systems.

Key executives identified in publicly available company materials include:

• Dr. Rahul Kushwah – Chief Executive Officer
• Michael Lende – Former President and Director
• Dr. Rohan Diwan – Director and technology leadership roles referenced in company disclosures
• Ajit Singh – Executive leadership roles referenced in public company materials

Public governance information available through filings and market disclosures remains relatively limited compared with larger exchange-listed issuers. Certain executive appointments, board composition details, and governance updates may have changed over time, and some information is inconclusive based on available public sources.